baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Discount Zert BNTX.../ DE000ME5FHZ9 /

19/09/2024 21:50:29	Chg.-0.36	Bid22:00:35	Ask22:00:35	Underlying	Strike price	Expiration date	Option type
62.55EUR	-0.57%	- Bid Size: -	- Ask Size: -	BioNTech SE	- USD	27/06/2025	Call

GlobeNewswire 29/08 Advanced Medical Balloons appoints top-performing US life-science executive to drive business growth

TeleTrader 22/08 FDA okays Moderna, Pfizer updated vaccines

GlobeNewswire 22/08 Pfizer and BioNTech Receive U.S. FDA Approval & Authorization for Omicron KP.2-adapted COVID-19 Vacc...

GlobeNewswire 16/08 Pfizer and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and C...

GlobeNewswire 14/08 Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update

GlobeNewswire 08/08 Genmab Announces Financial Results for the First Half of 2024

GlobeNewswire 08/08 Genmab Updates 2024 Financial Guidance

TeleTrader 05/08 BioNTech posts revenue at €128.7 billion in Q2

GlobeNewswire 05/08 BioNTech Announces Second Quarter 2024 Financial Results and Corporate Update

GlobeNewswire 05/08 Genmab Takes Full Control of Acasunlimab Development Program

GlobeNewswire 01/08 Arbutus Reports Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 30/07 BioNTech Announces Positive Topline Phase 2 Results for mRNA Immunotherapy Candidate BNT111 in Patie...

GlobeNewswire 22/07 BioNTech to Report Second Quarter 2024 Financial Results and Corporate Update on August 5, 2024

GlobeNewswire 27/06 Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the E...

GlobeNewswire 24/06 BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT...

GlobeNewswire 01/06 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...

GlobeNewswire 29/05 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem

GlobeNewswire 21/05 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...

GlobeNewswire 21/05 Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announ...

GlobeNewswire 17/05 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024

GlobeNewswire 17/05 Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates

GlobeNewswire 09/05 Matinas BioPharma Reports First Quarter 2024 Financial Results and Provides a Business Update

TeleTrader 06/05 BioNTech's Q1 revenue slumps 85% to €187.6M

GlobeNewswire 06/05 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update

TeleTrader 06/05 Europe mixed premarket with data on the limelight

Morgan Stanley Discount Zert BNTX.../ DE000ME5FHZ9 /

If you wish to receive reply to your feedback, please provide your email address.